Adimmune

Certification

  1. 2021
    • The second fill and finish line received TFDA GMP certification.

      The second fill and finish line received TFDA GMP certification.

  1. 2020
    • Received GMP certification from Health Canada.

      Received GMP certification from Health Canada.

  1. 2018
    • Received GMP certification from Brazil ANVISA.

      Received GMP certification from Brazil ANVISA.

    • Received GMP certification from EU EMA.

      Received GMP certification from EU EMA.

  1. 2017
    • Received GMP certification from FDA Thailand.

      Received GMP certification from FDA Thailand.

    • Passed TFDA PIC/S GMP routine inspection.

      Passed TFDA PIC/S GMP routine inspection.

  1. 2016
    • Passed US FDA GMP inspection.

      Passed US FDA GMP inspection.

  1. 2014
    • Received first PIC/S GMP certification from the Ministry of Health and Welfare.

      Received first PIC/S GMP certification from the Ministry of Health and Welfare.

  1. 2013
    • Received GMP certification from Korea.

      Received GMP certification from Korea.

  1. 2010
    • Received the Merit Medal Award from Executive Yuan for work on epidemic control of Influenza A (H1N1).

      Received the Merit Medal Award from the Executive Yuan for pandemic control of A/H1N1 influenza

    • Passed Symbol of National Quality / National Biotechnology & Medical Care Quality Award (SNQ).

      Received certification of National Quality / National Biotechnology & Medical Care Quality Award (SNQ).

    • Adimmune get certificate of GMP compliance of a manufaturer from EMA in November, 2010。

      PassedEMA GMP inspection in November of 2010。

  1. 2009
    • Received the Class 1 Merit Medal Award from Executive Yuan for work on epidemic control of Influenza A (H1N1).

      Received the Merit Medal Award from the Executive Yuan for pandemic control of A/H1N1 influenza

  1. 2008
    • Receive patent for “Japanese Encephalitis DNA Vaccine.”

      Received Taiwan patent for “Japanese Encephalitis DNA Vaccine.”

  1. 2007
    • Signed strategic alliance with Crucell B.V. of Netherlands

      Signed strategic alliance agreements with Crucell

  1. 2005
    • Press conference for technological collaboration between ADIM and Kitasato for the new Flu Vaccine Plant.

      Press conference for technological collaboration between Adimmune and Kitasato Institute for the new influenza vaccine plant

  1. 1999
    • Received Award for Biotechnology Industry Development by the Taiwan Bio Industry Organization.

      Received "Award for Biotechnology Industry Development" by the Taiwan Bio Industry Organization.

  1. 1992
    • 榮獲中華民國生物產業發展協會「第五屆優良生物科技產業發展獎」。

      Passed pharmaceutical GMP inspection as a qualified biological product manufacturer. Started mass production of GMP grade vaccines.